Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.
Bugatti S, De Stefano L, Balduzzi S, Greco MI, Luvaro T, Cassaniti I, Bogliolo L, Mazzucchelli I, D'Onofrio B, di Lernia M, Mauric E, Lilleri D, Baldanti F, Manzo A, Montecucco C. Bugatti S, et al. Ann Rheum Dis. 2021 Dec;80(12):1635-1638. doi: 10.1136/annrheumdis-2021-220862. Epub 2021 Jun 25. Ann Rheum Dis. 2021. PMID: 34172502 No abstract available.
Inflammatory correlates of the Patient Global Assessment of Disease Activity vary in relation to disease duration and autoantibody status in patients with rheumatoid arthritis.
Bugatti S, De Stefano L, D'Onofrio B, Nicrosini A, Mauric E, di Lernia M, Sakellariou G, Favalli EG, Manzo A, Caporali R, Montecucco C. Bugatti S, et al. Ann Rheum Dis. 2022 Sep;81(9):1206-1213. doi: 10.1136/annrheumdis-2022-222436. Epub 2022 May 27. Ann Rheum Dis. 2022. PMID: 35623639
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs.
De Stefano L, Balduzzi S, Bogliolo L, D'Onofrio B, di Lernia M, Mauric E, Milanesi A, Brandolino F, Rocca C, Chiricolo S, Manzo A, Montecucco C, Bugatti S. De Stefano L, et al. Clin Exp Rheumatol. 2023 Mar;41(3):667-675. doi: 10.55563/clinexprheumatol/0ltj1i. Epub 2022 Sep 21. Clin Exp Rheumatol. 2023. PMID: 36135948 Free article.
Seronegative rheumatoid arthritis: one year in review 2023.
De Stefano L, D'Onofrio B, Gandolfo S, Bozzalla Cassione E, Mauro D, Manzo A, Ciccia F, Bugatti S. De Stefano L, et al. Clin Exp Rheumatol. 2023 Mar;41(3):554-564. doi: 10.55563/clinexprheumatol/go7g26. Epub 2023 Mar 23. Clin Exp Rheumatol. 2023. PMID: 36971084 Free article. Review.
285 results